Cardia Bioplastics Limited
Myeco Group Ltd, together with its subsidiaries, develops, manufactures, and sells sustainable packaging materials in Oceanic, Asia, the United States, Europe, and Africa. The company supplies biodegradable and compostable resins, packaging products, and cast films to blue-chip companies. It manufactures and distributes polyethylene films, renewable resources resins, and finished products. The co… Read more
Cardia Bioplastics Limited (SCGRF) - Total Liabilities
Latest total liabilities as of June 2024: $4.02 Million USD
Based on the latest financial reports, Cardia Bioplastics Limited (SCGRF) has total liabilities worth $4.02 Million USD as of June 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Cardia Bioplastics Limited - Total Liabilities Trend (2019–2024)
This chart illustrates how Cardia Bioplastics Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Cardia Bioplastics Limited Competitors by Total Liabilities
The table below lists competitors of Cardia Bioplastics Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Daedong Steel Co. Ltd
KQ:048470
|
Korea | ₩25.08 Billion |
|
RTG Mining Inc
PINK:RTTGF
|
USA | $2.17 Million |
|
Metalicity Limited
STU:P8O
|
Germany | €602.16K |
|
Domo Activos Socimi SA
MC:DOMO
|
Spain | €263.11K |
|
Microfriend Inc
KQ:147760
|
Korea | ₩37.56 Billion |
|
Ziga Innovation Public Company Limited
BK:ZIGA
|
Thailand | ฿337.49 Million |
|
Willbes
KO:008600
|
Korea | ₩199.46 Billion |
|
Rigel Resource Acquisition Corp.
OTCGREY:RRACF
|
USA | $34.77 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down Cardia Bioplastics Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.81 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cardia Bioplastics Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cardia Bioplastics Limited (2019–2024)
The table below shows the annual total liabilities of Cardia Bioplastics Limited from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-06-30 | $4.02 Million | -16.77% |
| 2023-06-30 | $4.83 Million | -26.30% |
| 2022-06-30 | $6.55 Million | +43.94% |
| 2021-06-30 | $4.55 Million | +3.96% |
| 2020-06-30 | $4.38 Million | -4.17% |
| 2019-06-30 | $4.57 Million | -- |